| 2024-06-21 | Sale | ANI Pharmaceuticals, Inc. ANIP | HEAD OF R&D, COO-NOVITIUM OPS | 20,000 0.0866% | $58.90 | $1.18M | +8.5% | |
| 2024-06-20 | Sale | ANI Pharmaceuticals, Inc. ANIP | HEAD OF R&D, COO-NOVITIUM OPS | 11,447 0.0503% | $59.86 | $685,217 | +5.78% | |
| 2024-06-18 | Sale | ANI Pharmaceuticals, Inc. ANIP | HEAD OF R&D, COO-NOVITIUM OPS | 10,607 0.0474% | $60.76 | $644,481 | +0.6% | |
| 2024-06-17 | Sale | ANI Pharmaceuticals, Inc. ANIP | HEAD OF R&D, COO-NOVITIUM OPS | 7,946 0.0359% | $61.41 | $487,964 | -1.68% | |
| 2024-05-20 | Sale | ANI Pharmaceuticals, Inc. ANIP | HEAD OF R&D, COO-NOVITIUM OPS | 12,855 0.0614% | $61.81 | $794,568 | +2.61% | |
| 2024-05-17 | Sale | ANI Pharmaceuticals, Inc. ANIP | HEAD OF R&D, COO-NOVITIUM OPS | 5,836 0.0269% | $62.09 | $362,357 | +2.96% | |
| 2024-05-16 | Sale | ANI Pharmaceuticals, Inc. ANIP | HEAD OF R&D, COO-NOVITIUM OPS | 16,459 0.078% | $63.84 | $1.05M | -0.82% | |
| 2024-05-15 | Sale | ANI Pharmaceuticals, Inc. ANIP | HEAD OF R&D, COO-NOVITIUM OPS | 14,850 0.0719% | $65.86 | $978,021 | -2.44% | |
| 2024-04-19 | Sale | ANI Pharmaceuticals, Inc. ANIP | HEAD OF R&D, COO-NOVITIUM OPS | 16,809 0.0797% | $65.17 | $1.1M | -0.79% | |
| 2024-04-18 | Sale | ANI Pharmaceuticals, Inc. ANIP | HEAD OF R&D, COO-NOVITIUM OPS | 10,423 0.05% | $64.98 | $677,287 | +0.6% | |
| 2024-04-17 | Sale | ANI Pharmaceuticals, Inc. ANIP | HEAD OF R&D, COO-NOVITIUM OPS | 9,520 0.0451% | $65.40 | $622,608 | -0.84% | |
| 2024-04-16 | Sale | ANI Pharmaceuticals, Inc. ANIP | HEAD OF R&D, COO-NOVITIUM OPS | 5,834 0.028% | $66.20 | $386,211 | -0.98% | |
| 2024-04-15 | Sale | ANI Pharmaceuticals, Inc. ANIP | HEAD OF R&D, COO-NOVITIUM OPS | 7,414 0.0352% | $66.33 | $491,771 | -2.04% | |
| 2024-03-08 | Sale | ANI Pharmaceuticals, Inc. ANIP | HEAD OF R&D, COO-NOVITIUM OPS | 10,000 0.0474% | $67.17 | $671,700 | -2.13% | |
| 2024-03-07 | Sale | ANI Pharmaceuticals, Inc. ANIP | HEAD OF R&D, COO-NOVITIUM OPS | 15,085 0.0714% | $66.35 | $1M | -0.77% | |
| 2024-03-06 | Sale | ANI Pharmaceuticals, Inc. ANIP | HEAD OF R&D, COO-NOVITIUM OPS | 14,822 0.0727% | $65.47 | $970,396 | +0.51% | |
| 2024-03-05 | Sale | ANI Pharmaceuticals, Inc. ANIP | HEAD OF R&D, COO-NOVITIUM OPS | 10,093 0.0493% | $65.35 | $659,578 | +1.15% | |
| 2024-01-23 | Sale | ANI Pharmaceuticals, Inc. ANIP | HEAD OF R&D, COO-NOVITIUM OPS | 15,000 0.0734% | $56.44 | $846,600 | +15.86% | |
| 2024-01-22 | Sale | ANI Pharmaceuticals, Inc. ANIP | HEAD OF R&D, COO-NOVITIUM OPS | 5,692 0.0278% | $55.95 | $318,467 | +16.57% | |
| 2024-01-19 | Sale | ANI Pharmaceuticals, Inc. ANIP | HEAD OF R&D, COO-NOVITIUM OPS | 4,524 0.0222% | $55.57 | $251,399 | +17.17% |